Literature DB >> 31395454

Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy".

Omesh Kumar Bharti1, Baldev Thakur2, Ranjna Rao3.   

Abstract

Since 2008, we in Himachal Pradesh have used a "pooling strategy" to help patients save money by pooling vials of antirabies vaccine at a centralized hospital and sharing them using the intradermal technique. In 2014, there was an acute shortage of rabies immunoglobulins (RIG) and two patients died after four injections of rabies vaccine were administered without RIG, which was not commercially available. After an extensive literature review and technical and ethical committee clearances, in June 2014 we started to infiltrate equine RIG (eRIG) into wound/s only without the recommended systemic intramuscular (IM) injection. WHO recommended this technique in 2018. During the four-year period June 2014 to June 2018, 7506 of 10,830 patients exposed to suspected rabid animals were injected with eRIG in and around the wounds in a single clinic at DDU Hospital Shimla without any adverse outcomes. The average volume of eRIG used per patient was 0.75 mL and cost US$ 0.75. Of the 80% of patients who were followed up, all were healthy at the end of a year, including 26 patients bitten by laboratory-confirmed rabid dogs. The reaction rate after PEP administration also declined significantly. Since February 2018, Himachal has started following the new WHO recommendations on PEP regimens of three intradermal antirabies vaccines instead of four, thereby saving hundreds of vaccine vials that became useful during shortages of rabies vaccine in India. To date, more than 700 vaccine vials have been saved in a single clinic at DDU hospital during the past 6 months alone. Not giving PEP to patients who have consumed raw milk from a suspected rabid cow has also saved 62 vials. Currently, 90 "pooling centers" have been established for sharing of vaccine and eRIG vials in Himachal State, generating huge savings that have enabled the government to provide PEP free of charge to all. The new WHO guidelines are a positive step towards a rabies-free world by 2030.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Low cost; Post exposure prophylaxis; Rabies; Rabies Immunoglobulins

Mesh:

Substances:

Year:  2019        PMID: 31395454     DOI: 10.1016/j.vaccine.2019.07.087

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Implementation of Clinical Decision Support on Emergency Department Delivery of Human Rabies Immune Globulin.

Authors:  Fangzheng Yuan; Tomona Iso; Elsie Rizk; R Benjamin Saldana; Anh Thu Tran; Ngoc-Anh A Nguyen; Prasanth R Boyareddigari; Daniela Espino; Joshua T Swan
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study.

Authors:  Rita V Burke; Pierantonio Russo; Michael Sicilia; William Wolowich; Novinyo Amega; Huy-Binh Nguyen
Journal:  BMJ Open       Date:  2022-04-26       Impact factor: 3.006

3.  A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis.

Authors:  Monir Ejemel; Todd G Smith; Lauren Greenberg; William C Carson; David Lowe; Yong Yang; Felix R Jackson; Clint N Morgan; Brock E Martin; Chantal Kling; Christina L Hutson; Nadia Gallardo-Romero; James A Ellison; Susan Moore; Adam Buzby; John Sullivan-Bolyai; Mark Klempner; Yang Wang
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

4.  Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures - an exploratory study.

Authors:  Ravish S Haradanhalli; Nitu Kumari; Mysore K Sudarshan; D H Ashwath Narayana; Ramya M Prashanth; Jithin Surendran
Journal:  Hum Vaccin Immunother       Date:  2022-01-21       Impact factor: 3.452

5.  A shorter post-exposure prophylaxis regimen for rabies, Pakistan.

Authors:  Naseem Salahuddin; Nadia Ansari; Muhammad Aftab Gohar
Journal:  Bull World Health Organ       Date:  2021-04-29       Impact factor: 9.408

6.  Abandon of intramuscular administration of rabies immunoglobulin for post-exposure prophylaxis in the revised guidelines in the Netherlands in 2018: cost and volume savings.

Authors:  Imke Schreuder; Cornelis De Pijper; Rob van Kessel; Leo Visser; Hans van den Kerkhof
Journal:  Euro Surveill       Date:  2020-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.